Multiple Sclerosis
Multiple Sclerosis (MS) is one the deadliest diseases that effects the brain, spine and the central nervous system (CNS). MS is a progressive immune-mediated disease that has an onset stage between ages 20-40 which is affecting 2.5 million people globally (Burke, Hooper, Barlow & Hatter (2013). The onset of multiple sclerosis attacks the immune system which slows down the communication of the brain to the other parts of the body. The immune system begins to breakdown leading to the nerve deterioration that can be permanent. The signs and symptoms can be varied depending on the severity and which specific nerves that are being impacted. However, the common multiple sclerosis symptoms affect the spinal cord, brain, numbness, and blurred vision (Burke, Hooper, Barlow & Hatter (2013). In the more severe cases individuals may lose the ability to walk while others may experience less difficulties with fewer new symptoms. The healthcare industry is still searching for a cure however as of today, there is no cure for Multiple sclerosis (MS). …show more content…
These drugs can not cure the MS disease but they can slow down the deliberating affects allowing the individual to manage the disease and improve quality of life. There are other disease modifying drugs that can help management MS called aubagio, avonex, bataseron and gilenya. However, Palmer suggest the new drugs treatments such as natalizumab, fingolimod, dimethyl and terifluomide have success targeting the interaction of the CNS and the leukocytes. The drug treatment plan does not cure the MS however; they drug regiment prevents the frequency of major MS attacks. The secondary treatment benefits are to prevent any new brain lesions from developing. A life with MS is never a comfortable one however, the drugs can improve the individual’s quality of
Multiple Sclerosis (MS) is one the deadliest diseases that effects the brain, spine and the central nervous system (CNS). MS is a progressive immune-mediated disease that has an onset stage between ages 20-40 which is affecting 2.5 million people globally (Burke, Hooper, Barlow & Hatter (2013). The onset of multiple sclerosis attacks the immune system which slows down the communication of the brain to the other parts of the body. The immune system begins to breakdown leading to the nerve deterioration that can be permanent. The signs and symptoms can be varied depending on the severity and which specific nerves that are being impacted. However, the common multiple sclerosis symptoms affect the spinal cord, brain, numbness, and blurred vision (Burke, Hooper, Barlow & Hatter (2013). In the more severe cases individuals may lose the ability to walk while others may experience less difficulties with fewer new symptoms. The healthcare industry is still searching for a cure however as of today, there is no cure for Multiple sclerosis (MS). …show more content…
These drugs can not cure the MS disease but they can slow down the deliberating affects allowing the individual to manage the disease and improve quality of life. There are other disease modifying drugs that can help management MS called aubagio, avonex, bataseron and gilenya. However, Palmer suggest the new drugs treatments such as natalizumab, fingolimod, dimethyl and terifluomide have success targeting the interaction of the CNS and the leukocytes. The drug treatment plan does not cure the MS however; they drug regiment prevents the frequency of major MS attacks. The secondary treatment benefits are to prevent any new brain lesions from developing. A life with MS is never a comfortable one however, the drugs can improve the individual’s quality of